As we mentioned in previous articles, the life expectancy in developed countries continues to rise, reaching an average of 81 years in Europe, according to 2019 data from the Spanish National Statistics Institute. However, this increase in life expectancy is accompanied by an increase in chronic diseases, with the burden on the healthcare system that this implies.
Currently, as we know, healthcare products must demonstrate their safety and efficacy through the completion of multiple clinical trials, passing through a strict regulatory process before their approval. However, there are situations in which early access to certain treatments and therapies is vital for patients suffering from critical and rare diseases.
The extended use of the Internet of Things in all areas of life, as well as the growth and continuous improvement of Artificial Intelligence is generating an increasing interest in the development of virtual worlds and digital twins, which are virtual replicas of an object or system in the physical world. These virtual twins use simulation, machine learning, and logic to help in decision-making.
After diagnosis, oncology patients begin a process of periodic follow-up by their specialist, who is in charge of evaluating the patient’s health, treatment, symptoms, adverse events, etc., all vitally important for the management of the disease.
This enables them to determine the patient’s general status, and its impact on his or her quality of life.
The “ColonSee” project, implemented at the Hospital Clinic of Barcelona in collaboration with our company, Persei vivarium, helps to improve the management of patients with scheduled colonoscopies
The project “ColonSee”, designed by the Gastroenterology Service at the Hospital Clinic of Barcelona in collaboration with our company, is improving the management, preparation, and follow-up of patients with a scheduled colonoscopy.
Participatory Medicine marks the beginning of very real changes in the way healthcare is provided now. For a long time, most interactions between the doctor and the patient have been largely directed by the doctor. Now, this focus is changing towards a participatory medicine in which the patient plays an active role in the process of care.